Joseph H. Wender, Director at IONIS PHARMACEUTICALS INC (IONS), sold 28,000 shares at $55.04 ($1.6M) on 2025-09-02, disclosed to the SEC on 2025-09-04.
Scheduled sale ($1.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.04 | 11,200 | $616K | 38.2% |
| 2 | $57.53 | 5,600 | $322K | 20.0% |
| 3 | $60.14 | 11,200 | $674K | 41.8% |
| Total | $57.58 avg | 28,000 | $1.6M | 100% |
| Filing → |
| IONS | SELL | 2025-10-02 | $1.1M | — | Filing → |
| IONS | SELL | 2019-03-20 | $796K | — | Filing → |
| IONS | SELL | 2018-05-11 | $1.3M | — | Filing → |